Hutch News

Hutch News

Stories tagged 'Peter Nelson'

Science to watch in 2018: From immunotherapy to gene therapy, big data to new tech

Fred Hutch experts lend their predictions for the coming year’s advances

Jan. 12, 2018 | By Rachel Tompa / Fred Hutch News Service

We asked Fred Hutch researchers for their predictions on scientific advances to watch in the coming year. Look for their tips on what's next in cancer immunotherapy, precision oncology, gene editing, infectious disease research, cancer prevention and more.

View story >


'Movember' a reminder for dudes to go to the doctor

Growing facial hair in November part of spotlight on men’s health awareness — and the lack thereof

Nov. 28, 2017 | By Diane Mapes / Fred Hutch News Service

Many men loathe going to the doctor — often to their detriment — but the global organization Movember is trying to change that by encouraging men to grow mustaches (or “mo’s”) during November to raise awareness and funds for men’s health research. Fred Hutch's Dr. Pete Nelson weighs in.

View story >


Targeted therapies push metastatic prostate cancer in new directions

Combination therapy could help stave off new “escape variant” of disease that arises in response to powerful treatments

Nov. 14, 2017 | By Sabrina Richards / Fred Hutch News Service

Dr. Pete Nelson and colleagues found that as hormone-targeting treatments grow more potent, recurrent prostate tumors are more often finding a new way around the drugs.

View story >


Removing barriers to precision treatment of metastatic prostate cancer

GENTleMEN study aims to help men with advanced disease access genetic testing and counseling

Oct. 30, 2017 | By Sabrina Richards / Fred Hutch News Service

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Oct. 19, 2017

Dr. Ruth Etzioni, a Fred Hutch biostatistician, has received a five-year National Institutes of Health grant to advance the science of cancer surveillance by developing, validating and deploying a scalable, automated approach for identifying cancer recurrence.

View story >


The path to precision screening for cancer

For now, early detection of breast and prostate cancer means mammograms and PSAs, but a more tailored approach is on the horizon

Sept. 29, 2017 | By Diane Mapes / Fred Hutch News Service

For now, screening for breast and prostate cancer involves mammograms, MRIs and PSAs, the best evidence-based tools available at this moment in time. But it won’t be this way forever. Fred Hutch researchers weigh in on where we are on the path to precision prevention.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.